Hattie Hayes

In the clinical trial, Oxurion’s novel PKal Inhibitor, THR-149, did not meet its primary endpoint

Infrastructure across Europe needs a major overhaul to optimise education and patient access in groundbreaking treatments

The company received marketing authorisation approval in the EU earlier this year

The endorsement follows FDA approval in the United States this summer

At this year's American Academy of Ophthalmology meeting, Anthony Wallace, BS, MBA, vice president and general manager of the surgical business at Bausch + Lomb North America, spoke with us about three exciting new launches

The ESCRS Symposium focused on innovations in the digital cataract and refractive surgery space

The highlights from this year’s meeting, brought to you in conjunction with Modern Retina

Study results indicated low-light therapy can help prevent dry eye disease following cataract surgery

Dr Ali Erginay of Lariboisière Hospital in Paris, France, discusses his EURETINA presentation, "Introducing optomap® Ultra-widefield Colour Red-Green-Blue Multimodal Imaging"

Attendees share their favorite moments and memories from the 2023 ESCRS meeting

The new range of pure and premixed gases are intended for medium-term use in retinal surgery

The approach to lowering intraocular pressure reduces medication burden without risking graft rejection

We asked attendees and presenters to share their highlights from this year's ESCRS meeting, which included favorites from the official programme and beyond

In the years to come, Ciliatech will release more data around their novel Cilioscleral Interposition Device (CID)

The future of refractive surgery is bright, thanks to OCTs and advances in laser technology

At the meeting, ZEISS Meditec Ophthalmology showcased the VISUMAX 800 and a host of new launches

The medical director for Optegra has piloted corneal workflows and trifocal lenses presented at the meeting

The director of Frankfurt’s Bürgerhospital eye hospital shared 7 years’ data on the iStent inject®

The glaucoma specialist spoke about his ESCRS agenda–and his calendar for 2024

The diagnostics company is using AI to screen for diabetic retinopathy, glaucoma and age-related macular degeneration

New cataract and refractive options from STAAR Surgical could come as early as this year

Two members of the team gave a preview of Geuder’s 2024 spotlight products

As part of the meeting’s MIGS programme, Keith Barton, MD, FRCP, FRCS, FRCOphth, shared data from the iTrack™ Global Data Registry

The nonprofit marked a major milestone by announcing a suite of webinars with Heidelberg Engineering

The diagnostic imaging experts will provide education through the Cybersight platform

In a conversation at ESCRS, the CEO said by 2028, Aurion Biotech hopes to see global registration for its corneal endothelial disease therapies.

Novartis acquired Gyroscope Holdings Limited from Syncona in February 2022

At this year's ESCRS meeting, we visited the Oertli Instruments booth, where co-CEO and co-owner Thomas Bosshard highlighted the company's 3-platform approach.

At the 2023 European Society Of Cataract & Refractive Surgeons (ESCRS) meeting in Vienna, Krysten Williams, head of marketing and education at Heidelberg Engineering, spoke to our team about the newest imaging advancements in the clinic and the operating room.

Jorge Alio, MD, PhD, FEBOpthhal spoke with our team about his Binkhorst Medal lecture topic, the future of cataract and refractive surgery, while at the 2023 ESCRS meeting in Vienna, Austria.